Profiel
Karl David Pechmann is currently an Associate at Governance Institute of Australia Ltd., a Member of Chartered Accountants Australia & New Zealand, and will be Chief Financial Officer at EMvision Medical Devices Ltd. starting in 2026.
Former roles include Finance Director at Immutep Ltd., COO, Chief Financial Officer & Joint Secretary at Genetic Signatures Ltd. from 2023 to 2026, Chief Financial Officer & Secretary at OncoSil Medical Ltd. from 2020 to 2023, and Chief Financial Officer & Secretary at Kyckr Ltd. from 2016 to 2020.
Education includes an undergraduate degree from the University of Technology Sydney, conferred in 2004.
Actieve functies van Karl Pechmann
| Bedrijven | Functie | Begin |
|---|---|---|
| EMVISION MEDICAL DEVICES LTD | Financieel Directeur/CFO | 01-02-2026 |
Chartered Accountants Australia & New Zealand
Chartered Accountants Australia & New Zealand Miscellaneous Commercial ServicesCommercial Services Operates as an association for charted accountants and provides accounting services | Corporate Officer/Principal | - |
Governance Institute of Australia Ltd.
Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Provides education, support and networking opportunities for directors, company secretaries, governance advisers and risk managers | Corporate Officer/Principal | - |
Eerdere bekende functies van Karl Pechmann
| Bedrijven | Functie | Einde |
|---|---|---|
| GENETIC SIGNATURES LIMITED | Financieel Directeur/CFO | 30-01-2026 |
| ONCOSIL MEDICAL LIMITED | Financieel Directeur/CFO | 24-05-2023 |
| KYCKR LIMITED | Financieel Directeur/CFO | 16-03-2020 |
| IMMUTEP LIMITED | Financieel Directeur/CFO | - |
Opleiding van Karl Pechmann
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Immutep Ltd.
Immutep Ltd. BiotechnologyHealth Technology Engages in the development of anti-cancer therapeutics | Health Technology |
Genetic Signatures Ltd.
Genetic Signatures Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes diagnostic kits | Commercial Services |
OncoSil Medical Ltd.
OncoSil Medical Ltd. Medical SpecialtiesHealth Technology Develops and commercializes neurology services including those for pancreatic cancer | Health Technology |
University of Technology Sydney
University of Technology Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Governance Institute of Australia Ltd.
Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Provides education, support and networking opportunities for directors, company secretaries, governance advisers and risk managers | Commercial Services |
Chartered Accountants Australia & New Zealand
Chartered Accountants Australia & New Zealand Miscellaneous Commercial ServicesCommercial Services Operates as an association for charted accountants and provides accounting services | Commercial Services |
Kyckr Ltd.
Kyckr Ltd. Packaged SoftwareTechnology Services Builds and develops software products and API platform to provides KYC and data compliance solutions | Technology Services |
EMvision Medical Devices Ltd.
EMvision Medical Devices Ltd. Medical SpecialtiesHealth Technology Develops and supplies medical imaging technology | Health Technology |
















